Approval Probability 71%
TA Base Rate26%
Adjusted LOA41%
ML RiskLOW_RISK
| NCT ID | Title | Phase | Status | Enrollment | Velocity | Design | Start | Completion | Last Updated | Sites | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|
| NCT01514578 | Single Ascending Dose Study of Intravenous TRV130A in Healthy Adult Males | PHASE1 | COMPLETED | 74 | — | — | Jan 1, 2012 | Jul 1, 2012 | Aug 24, 2012 | 1 | United States |
| Arm | Type | Description |
|---|---|---|
| TRV130A | EXPERIMENTAL | - |
| Dextrose in Water | PLACEBO_COMPARATOR | - |
| Name | Type | Description |
|---|---|---|
| TRV130A | DRUG | Intravenous infusion of 1 hour duration |
| Dextrose in Water | DRUG | Intravenous infusion of 1 hour duration |
Inclusion Criteria: * Healthy adult male 19 - 50 years of age * Body weight \>/= 50 kg * Capable of giving written informed consent Exclusion Criteria: * Clinically significant disease or conditions that may place the subject at unacceptable risk as a participant in the study, or that may interfe...